Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-08

Clinical Trial Update: BEOVU Versus Eylea in the Treatment of Diabetic Macular Edema [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing BEOVU to Eylea for macular edema is underway, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BEOVU (BROLUCIZUMAB)
  • EYLEA (Aflibercept)

Snippet

Sponsor: Benha University | Conditions: Macular Edema | Phase 3 | Status: UNKNOWN